Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03469505 · ClinicalTrials.gov registry record · NA
Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)
A NA study of Pain, Chronic, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 764
- Enrollment target
- 9
- Study locations
NCT03469505: Completed NA study of Pain, Chronic, sponsored by Yale University.
NCT03469505 is a NA study of Pain, Chronic that has completed, run by Yale University. The registered enrollment target is 764 participants, roughly in line with the 706-participant average among 48 other Pain, Chronic trials with a reported enrollment target. The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03469505, a NA study of Pain, Chronic, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 764 participants
- Enrollment target
- 9
- Study locations
Study Summary
To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)
Primary Outcome
The BPI-I Score is patient-reported pain-related interference. BPI-I score range is 0 to 10. Higher scores indicate worse functioning.
Conditions Studied
Interventions
- BEHAVIORAL COPES
- BEHAVIORAL CBT-CP
Study Locations (9)
Texas
- VA North Texas Healthcare System - Dallas
- VA Central Texas Healthcare System - Temple
Illinois
- Edward Hines, Jr. VA Hospital - Hines
Massachusetts
- VA Central Western Massachusetts - Leeds
Michigan
- VA Ann Arbor Healthcare System - Ann Arbor
Mississippi
- G.V. (Sonny) Montgomery VA Medical Center - Jackson
Oklahoma
- Oklahoma City VA Health Care System - Oklahoma City
South Carolina
- Ralph H. Johnson VA Medical Center - Charleston
Washington
- VA Puget Sound Healthcare System - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 764 participants |
| Start Date | 2019-12-27 |
| Est. Completion | 2025-02-20 |
| Phase | NA |
What the finished NCT03469505 record still lists
NCT03469505 is an interventional study that assigns participants to a tested intervention. The registered 764 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 706-participant average among 48 other Pain, Chronic trials with a reported enrollment target.
The record links to 1 condition, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which COPES is the first listed.
NCT03469505 lists 9 locations in 8 states (Texas, Illinois, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03469505 about?
NCT03469505 is a clinical study titled "Cooperative Pain Education and Self-management: Expanding Treatment for Real-world Access (COPES ExTRA)". To conduct a superiority trial of COPES versus standard Veterans Health Administration (VHA) Cognitive Behavioral Therapy Chronic Pain (CBT-CP)
What is the current status of trial NCT03469505?
This trial is currently completed. It is a NA study. The enrollment target is 764 participants. The study started on 2019-12-27. Estimated completion is 2025-02-20.
What conditions does trial NCT03469505 study?
This clinical trial studies the following conditions: Pain, Chronic.
What interventions are being tested in trial NCT03469505?
The interventions under investigation include: COPES (BEHAVIORAL), CBT-CP (BEHAVIORAL).
Who is sponsoring clinical trial NCT03469505?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03469505 being conducted?
This trial has 9 study locations across Illinois, Massachusetts, Michigan, Mississippi, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03469505's enrollment target sits among peer trials
764 7th of 48 higher than 42 of 48 other Pain, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
RECRUITING · NA
-
Pain and Weight Treatment: Development and Trial of PAW
RECRUITING · NA
-
VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain
RECRUITING · NA
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
-
Pain and Opioid Management in Older Adults
RECRUITING · NA
-
Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578665 · 764 participants · NA
Human-like Robotic Controllers for Enhanced Motor Learning
- NCT05579366 · 764 participants · Phase 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- NCT03789552 · 765 participants · Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
- NCT07195591 · 766 participants · Phase 3
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI